146 related articles for article (PubMed ID: 10853236)
21. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
[TBL] [Abstract][Full Text] [Related]
22. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous triple organ specific autoantibody profiling in adult patients with type 1 diabetes mellitus and their first-degree relatives.
Dagdelen S; Hascelik G; Bayraktar M
Int J Clin Pract; 2009 Mar; 63(3):449-56. PubMed ID: 18218004
[TBL] [Abstract][Full Text] [Related]
24. Screening for coeliac disease in families of adults with Type 1 diabetes based on serological markers.
Matteucci E; Cinapri V; Quilici S; Lucchetti A; Mugnaini P; Giampietro O
Diabetes Nutr Metab; 2001 Feb; 14(1):37-42. PubMed ID: 11345164
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
Betterle C; Lazzarotto F; Fusari A; Zanchetta R; Benedini S; Pedini B; Moscon A; Presotto F
Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the GAD65-GAD65 autoantibody interaction.
Coco G; Chen S; Powell M; Brooking H; Zanchetta R; Betterle C; Smith BR; Furmaniak J
Clin Chim Acta; 2008 May; 391(1-2):51-9. PubMed ID: 18328264
[TBL] [Abstract][Full Text] [Related]
27. The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.
Petrone A; Suraci C; Capizzi M; Giaccari A; Bosi E; Tiberti C; Cossu E; Pozzilli P; Falorni A; Buzzetti R;
Diabetes Care; 2008 Mar; 31(3):534-8. PubMed ID: 18056891
[TBL] [Abstract][Full Text] [Related]
28. [Autoantibodies to GAD65, IA2 and insulin in Czech children with type 1 diabetes].
Cinek O; Pechová M; Kolousková S; Horká I; Sedláková P; Sumník Z; Snajderová M; Vavrinec J
Cas Lek Cesk; 2000 Sep; 139(19):599-603. PubMed ID: 11192752
[TBL] [Abstract][Full Text] [Related]
29. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
Khan MW; Sherwani S; Khan WA; Ali R
Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
[TBL] [Abstract][Full Text] [Related]
30. [Prevalence of anti-GAD autoantibodies in Tunisian children with type 1 diabetes].
Elkadhi A; Khelifi N; Abid A; Nagati K; Jenhani F; Ben Rayana MC
Tunis Med; 2002 May; 80(5):281-5. PubMed ID: 12534034
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune diabetes in adults: lessons from the UKPDS.
Desai M; Clark A
Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
[TBL] [Abstract][Full Text] [Related]
32. Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon.
Hawa MI; Picardi A; Costanza F; D'Avola D; Beretta Anguissola G; Guglielmi C; Mottini G; Fezeu L; Mbanya JC; Leslie RD; Pozzilli P
Clin Immunol; 2006; 118(2-3):229-32. PubMed ID: 16298164
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of carboxypeptidase-H autoantibodies in detecting latent autoimmune diabetes in adults.
Zhou ZG; Yang L; Huang G
Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):549-52. PubMed ID: 15804058
[TBL] [Abstract][Full Text] [Related]
34. Antigenic determinants to GAD autoantibodies in patients with type 1 diabetes with and without autoimmune thyroid disease.
Park H; Yu L; Kim T; Cho B; Kang J; Park Y
Ann N Y Acad Sci; 2006 Oct; 1079():213-9. PubMed ID: 17130557
[TBL] [Abstract][Full Text] [Related]
35. High-titer GAD65 autoantibodies detected in adult diabetes patients using a high efficiency expression vector and cold GAD65 displacement.
Hansson I; Lynch KF; Hallmans G; Lernmark Å; Rolandsson O
Autoimmunity; 2011 Mar; 44(2):129-36. PubMed ID: 20670115
[TBL] [Abstract][Full Text] [Related]
36. Determination of anti GAD65 autoantibodies with an ELISA before and after standardization with the new international reference serum.
Pfützner A; Forst T; Ambrosch A; Schmitz H; Lichtwald K; Beyer J
Exp Clin Endocrinol Diabetes; 1995; 103(2):123-5. PubMed ID: 7553076
[TBL] [Abstract][Full Text] [Related]
37. Detection of glutamic acid decarboxylase (GAD) autoantibodies by indirect immunofluorescence using CHO cells expressing recombinant human GAD65.
Papouchado ML; Ermácora MR; Poskus E
J Autoimmun; 1996 Oct; 9(5):689-97. PubMed ID: 8933286
[TBL] [Abstract][Full Text] [Related]
38. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
Verge CF; Stenger D; Bonifacio E; Colman PG; Pilcher C; Bingley PJ; Eisenbarth GS
Diabetes; 1998 Dec; 47(12):1857-66. PubMed ID: 9836516
[TBL] [Abstract][Full Text] [Related]
39. Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5).
Zampetti S; Spoletini M; Petrone A; Capizzi M; Arpi ML; Tiberti C; Di Pietro S; Bosi E; Pozzilli P; Giorgino F; Buzzetti R;
Diabet Med; 2010 Jun; 27(6):701-4. PubMed ID: 20546291
[TBL] [Abstract][Full Text] [Related]
40. [Autoantibodies against GAD, GAD65 and IA-2].
Tsujii S
Nihon Rinsho; 2002 Aug; 60 Suppl 8():395-400. PubMed ID: 12355780
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
